Substance Use Disorders and Diabetes Care

BACKGROUND: Individuals that have both diabetes and substance use disorder (SUD) are more likely to have adverse health outcomes and are less likely to receive high quality diabetes care, compared with patients without coexisting SUD. Care management programs for patients with chronic diseases, such as diabetes and SUD, have been associated with improvements in the process and outcomes of care. OBJECTIVE: The aim was to assess the impact of having coexisting SUD on diabetes process of care metrics. RESEARCH DESIGN: Preintervention/postintervention triple difference analysis. SUBJECTS: Participants in the New York State Medicaid Health Home (NYS-HH) care management program who have diabetes and a propensity-matched comparison group of nonparticipants (N=37,260). MEASURES: Process of care metrics for patients with diabetes: an eye (retinal) exam, HbA1c test, medical attention (screening laboratory measurements) for nephropathy, and receiving all 3 in the past year. RESULTS: Before enrollment in NYS-HH, individuals with comorbid SUD had fewer claims for eye exams and HbA1c tests compared with those without comorbid SUD. Diabetes process of care improvements associated with NYS-HH enrollment were larger among those with comorbid SUD [eye exam: adjusted odds ratio (AOR)=1.08; 95% confidence interval (CI): 1.01-1.15]; HbA1c test: AOR=1.20 (95% CI: 1.11-1.29); medical attention for nephropathy: AOR=1.21 (95% CI: 1.12-1.31); all 3: AOR=1.09 (95% CI: 1.02-1.16). CONCLUSIONS: Individuals with both diabetes and SUD may benefit moderately more from care management than those without comorbid SUD. Individuals with both SUD and diabetes who are not enrolled in care management may be missing out on crucial diabetes care

Comorbidity · Confidence interval · Diabetes management · Diabetes mellitus · Family medicine · Health care · Medicaid · Odds ratio · Type 2 diabetes · Diabetes Management and Education · Internal Medicine · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes

• Untreated substance use disorder affects glycemic control

  Open Access•Viviana Horigian, Viviana E Horigian et al.•Frontiers in Public Health•2023

  Incluir item

• Associations of Co-Occurring Substance Use Disorder With Diabetes Care Quality, Complications, and Hospitalizations

  Michele Knox, Dominic Hodgkin et al.•Medical Care•2025

  Incluir item

• The State of US Health, 1990-2016

  The US Burden of Disease Collaborators, Ali H Mokdad et al.•JAMA•2018

  Incluir item

• Dropout rates of in‐person psychosocial substance use disorder treatments

  Open Access•Sara Lappan, Andrew W Brown et al.•Addiction•2020

  Incluir item

• Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery

  Open Access•Leonieke C van Boekel, Evelien P M Brouwers et al.•Drug and Alcohol Dependence•2013

  Incluir item

• Economic Costs of Diabetes in the U.S. in 2017

  Open Access•American Diabetes Association•Diabetes Care•2018

  Incluir item

• Substance Use and Associated Health Conditions throughout the Lifespan

  Open Access•Marya T Schulte, Yih-Ing Hser•Public Health Reviews•2013

  Incluir item

• Advanced Issues in Propensity Scores

  Open Access•Kevin A Kupzyk, Kevin Kupzyk et al.•The Journal of Early Adolescence•2016

  Incluir item

• Not Alone Anymore”

  Victoria Mayer, Victoria L Mayer et al.•Medical Care•2020

  Incluir item

• Receipt of Diabetes Services by Insured Adults With and Without Claims for Mental Disorders

  Laura E Jones, William Clarke et al.•Medical Care•2004

  Incluir item